M&A Deal Summary

WuXi AppTec Acquires ResearchPoint Global

On October 17, 2017, WuXi AppTec acquired life science company ResearchPoint Global

Acquisition Highlights
  • This is WuXi AppTec’s 8th transaction in the Life Science sector.
  • This is WuXi AppTec’s 7th transaction in the United States.
  • This is WuXi AppTec’s 1st transaction in Texas.

M&A Deal Summary
Date 2017-10-17
Target ResearchPoint Global
Sector Life Science
Buyer(s) WuXi AppTec
Deal Type Add-on Acquisition

Target

ResearchPoint Global

Austin, Texas, United States
ResearchPoint Global is a full-service contract clinical research organization, with coverage in more than 60 countries. As a highly nimble organization with a unique blend of an experienced team, RPG provides a full range of CRO services, including project management, site selection and management, safety and medical monitoring, clinical monitoring, data management, biostatistics, as well as medical writing, across all phases of clinical development, including multi-regional clinical trials.

Search 199,712 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

WuXi AppTec

Shanghai, China
Category Company
Founded 2000
Sector Life Science
Employees38,134
Revenue 40.3B CNY (2023)
DESCRIPTION

WuXi AppTec is a provider of pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi AppTec was founded in 2000 and is based in Shanghai, China.

DEAL STATS #
Overall 11 of 15
Sector (Life Science) 8 of 11
Type (Add-on Acquisition) 11 of 13
State (Texas) 1 of 1
Country (United States) 7 of 9
Year (2017) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-31 STA Pharmaceutical

San Diego, California, United States

STA Pharmaceutical Co., Ltd. is a small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-18 Arrakis Therapeutics

Waltham, Massachusetts, United States

Arrakis Therapeutics is pioneering the discovery of small-molecule medicines that directly bind to and modify the biological function of RNA to treat disease. This new class of medicines, RNA-targeted small molecules (rSMs), can unlock the therapeutic potential of deeply researched, valuable targets that are not accessible at the level of their expressed, undruggable protein. Arrakis Therapeutics was founded in 2015 and is based in Waltham, Massachusetts.

Buy -
Mergr

Product

Company

Legal